Literature DB >> 35133429

Fourth COVID-19 Vaccine Dose Increases Low Antibodies.

Jennifer Abbasi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35133429     DOI: 10.1001/jama.2022.0727

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Expected cost effectiveness of the fourth dose of COVID-19 vaccine against the omicron variant of COVID-19: a preliminary report.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-08-15

2.  Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?

Authors:  Masoud Keikha
Journal:  Vacunas       Date:  2022-06-17

3.  Antibody Responses after Two Doses of COVID-19 mRNA Vaccine in Dialysis and Kidney Transplantation Patients Recovered from SARS-CoV-2 Infection.

Authors:  Maria Cappuccilli; Simona Semprini; Elisabetta Fabbri; Michela Fantini; Paolo Ferdinando Bruno; Alessandra Spazzoli; Matteo Righini; Marta Flachi; Gaetano La Manna; Vittorio Sambri; Giovanni Mosconi
Journal:  Medicina (Kaunas)       Date:  2022-07-03       Impact factor: 2.948

4.  Investigation of Possible Factors Influencing the Neutralizing Anti-SARS-CoV-2 Antibody Titer after Six Months from the Second Vaccination Dose in a Sample of Italian Nursing Home Personnel.

Authors:  Alberto Modenese; Stefania Paduano; Rossana Bellucci; Simona Marchetti; Fulvio Bruno; Pietro Grazioli; Roberto Vivoli; Fabriziomaria Gobba; Annalisa Bargellini
Journal:  Antibodies (Basel)       Date:  2022-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.